{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:24:12Z","timestamp":1791894252124,"version":"4.3.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T00:00:00Z","timestamp":1528416000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Epigenetics & Chromatin"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13072-018-0197-x","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T04:22:11Z","timestamp":1528431731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["CREBBP\/EP300 bromodomains are critical to sustain the GATA1\/MYC regulatory axis in proliferation"],"prefix":"10.1186","volume":"11","author":[{"given":"Veronica","family":"Garcia-Carpizo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ruiz-Llorente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinto","family":"Sarmentero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo","family":"Gra\u00f1a-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Barrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,8]]},"reference":[{"key":"197_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/20974","volume":"399","author":"C Dhalluin","year":"1999","unstructured":"Dhalluin C, Carlson JE, Zeng L, He C, Aggarwal AK, Zhou MM. Structure and ligand of a histone acetyltransferase bromodomain. Nature. 1999;399:491\u20136.","journal-title":"Nature"},{"key":"197_CR2","first-page":"D1008","volume":"6","author":"B Florence","year":"2001","unstructured":"Florence B, Faller DV. You bet-cha: a novel family of transcriptional regulators. Front Biosci. 2001;6:D1008\u201318.","journal-title":"Front Biosci"},{"key":"197_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.molcel.2005.06.027","volume":"19","author":"MK Jang","year":"2005","unstructured":"Jang MK, Mochizuki K, Zhou M, Jeong H-S, Brady JN, Ozato K. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell. 2005;19:523\u201334.","journal-title":"Mol Cell"},{"key":"197_CR4","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1017\/S1462399411001992","volume":"13","author":"S Muller","year":"2011","unstructured":"Muller S, Filippakopoulos P, Knapp S. Bromodomains as therapeutic targets. Expert Rev Mol Med. 2011;13:e29.","journal-title":"Expert Rev Mol Med"},{"key":"197_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature10509","volume":"478","author":"MA Dawson","year":"2011","unstructured":"Dawson MA, Prinjha RK, Dittmann A, Giotopoulos G, Bantscheff M, Chan W-I, Robson SC, Chung C, Hopf C, Savitski MM, Huthmacher C, Gudgin E, Lugo D, Beinke S, Chapman TD, Roberts EJ, Soden PE, Auger KR, Mirguet O, Doehner K, Delwel R, Burnett AK, Jeffrey P, Drewes G, Lee K, Huntly BJP, Kouzarides T. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature. 2011;478:529\u201333.","journal-title":"Nature"},{"key":"197_CR6","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, Philpott M, Munro S, McKeown MR, Wang Y, Christie AL, West N, Cameron MJ, Schwartz B, Heightman TD, La Thangue N, French CA, Wiest O, Kung AL, Knapp S, Bradner JE. Selective inhibition of BET bromodomains. Nature. 2010;468:1067\u201373.","journal-title":"Nature"},{"key":"197_CR7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Lov\u00e9n","year":"2013","unstructured":"Lov\u00e9n J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, Bradner JE, Lee TI, Young RA. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013;153:320\u201334.","journal-title":"Cell"},{"key":"197_CR8","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","volume":"155","author":"D Hnisz","year":"2013","unstructured":"Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andr\u00e9 V, Sigova AA, Hoke HA, Young RA. Super-enhancers in the control of cell identity and disease. Cell. 2013;155:934\u201347.","journal-title":"Cell"},{"key":"197_CR9","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.molcel.2015.04.011","volume":"58","author":"J-S Roe","year":"2015","unstructured":"Roe J-S, Mercan F, Rivera K, Pappin DJ, Vakoc CR. BET bromodomain inhibition suppresses the function of hematopoietic transcription factors in acute myeloid leukemia. Mol Cell. 2015;58:1028\u201339.","journal-title":"Mol Cell"},{"key":"197_CR10","doi-asserted-by":"publisher","first-page":"9308","DOI":"10.1021\/ja412434f","volume":"136","author":"DA Hay","year":"2014","unstructured":"Hay DA, Fedorov O, Martin S, Singleton DC, Tallant C, Wells C, Picaud S, Philpott M, Monteiro OP, Rogers CM, Conway SJ, Rooney TPC, Tumber A, Yapp C, Filippakopoulos P, Bunnage ME, M\u00fcller S, Knapp S, Schofield CJ, Brennan PE. Discovery and optimization of small-molecule ligands for the CBP\/p300 bromodomains. J Am Chem Soc. 2014;136:9308\u201319.","journal-title":"J Am Chem Soc"},{"key":"197_CR11","doi-asserted-by":"crossref","unstructured":"Chekler ELP, Pellegrino JA, Lanz TA, Denny RA, Flick AC, Coe J, Langille J, Basak A, Liu S, Stock IA, Sahasrabudhe P, Bonin PD, Lee K, Pletcher MT, Jones LH: Transcriptional profiling of a selective CREB binding protein bromodomain inhibitor highlights therapeutic opportunities. Chem Biol 2015:1588\u20131596.","DOI":"10.1016\/j.chembiol.2015.10.013"},{"key":"197_CR12","doi-asserted-by":"crossref","unstructured":"Picaud S, Fedorov O, Thanasopoulou A, Leonards K, Jones K, Meier J, Olzscha H, Monteiro O, Martin S, Philpott M, Tumber A, Filippakopoulos P, Yapp C, Wells C, Hing Che K, Bannister A, Robson S, Kumar U, Parr N, Lee K, Lugo D, Jeffrey P, Taylor S, Vecellio ML, Bountra C, Brennan P, O\u2019Mahony A, Velichko S, Muller S, Hay D, et al.: Generation of a selective small molecule inhibitor of the CBP\/p300 bromodomain for leukemia therapy. Cancer Res 2015, 44.","DOI":"10.1158\/0008-5472.CAN-15-0236"},{"key":"197_CR13","doi-asserted-by":"crossref","unstructured":"Xu M, Unzue A, Dong J, Spiliotopoulos D, Nevado C, Caflisch A: Discovery of CREBBP bromodomain inhibitors by high-throughput docking and hit optimization guided by molecular dynamics. J Med Chem 2015:150716130846002.","DOI":"10.1021\/acs.jmedchem.5b00171"},{"key":"197_CR14","doi-asserted-by":"publisher","first-page":"10549","DOI":"10.1021\/acs.jmedchem.6b01022","volume":"59","author":"TD Crawford","year":"2016","unstructured":"Crawford TD, Romero FA, Lai KW, Tsui V, Taylor AM, De Leon Boenig G, Noland CL, Murray J, Ly J, Choo EF, Hunsaker TL, Chan EW, Merchant M, Kharbanda S, Gascoigne KE, Kaufman S, Beresini MH, Liao J, Liu W, Chen KX, Chen Z, Conery AR, C\u00f4t\u00e9 A, Jayaram H, Jiang Y, Kiefer JR, Kleinheinz T, Li Y, Maher J, Pardo E, et al. Discovery of a potent and selective in vivo probe (GNE-272) for the bromodomains of CBP\/EP300. J Med Chem. 2016;59:10549\u201363.","journal-title":"J Med Chem"},{"key":"197_CR15","doi-asserted-by":"publisher","first-page":"13014","DOI":"10.1074\/jbc.M115.708560","volume":"291","author":"S Ghosh","year":"2016","unstructured":"Ghosh S, Taylor A, Chin M, Huang HR, Conery AR, Mertz JA, Salmeron A, Dakle PJ, Mele D, Cote A, Jayaram H, Setser JW, Poy F, Hatzivassiliou G, DeAlmeida-Nagata D, Sandy P, Hatton C, Romero FA, Chiang E, Reimer T, Crawford T, Pardo E, Watson VG, Tsui V, Cochran AG, Zawadzke L, Harmange JC, Audia JE, Bryant BM, Cummings RT, et al. Regulatory T cell modulation by CBP\/EP300 bromodomain inhibition. J Biol Chem. 2016;291:13014\u201327.","journal-title":"J Biol Chem"},{"key":"197_CR16","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.1158\/0008-5472.CAN-17-0314","volume":"77","author":"L Jin","year":"2017","unstructured":"Jin L, Garcia J, Chan E, de la Cruz C, Segal E, Merchant M, Kharbanda S, Raisner R, Haverty PM, Modrusan Z, Ly J, Choo E, Kaufman S, Beresini MH, Romero FA, Magnuson S, Gascoigne KE. Therapeutic targeting of the CBP\/p300 bromodomain blocks the growth of castration-resistant prostate cancer. Cancer Res. 2017;77:5564\u201375.","journal-title":"Cancer Res"},{"key":"197_CR17","doi-asserted-by":"publisher","first-page":"10768","DOI":"10.1073\/pnas.1501956112","volume":"112","author":"A Hammitzsch","year":"2015","unstructured":"Hammitzsch A, Tallant C, Fedorov O, O\u2019Mahony A, Brennan PE, Hay DA, Martinez FO, Al-Mossawi MH, de Wit J, Vecellio M, Wells C, Wordsworth P, M\u00fcller S, Knapp S, Bowness P. CBP30, a selective CBP\/p300 bromodomain inhibitor, suppresses human Th17 responses. Proc Natl Acad Sci. 2015;112:10768\u201373.","journal-title":"Proc Natl Acad Sci"},{"key":"197_CR18","doi-asserted-by":"publisher","first-page":"e10483","DOI":"10.7554\/eLife.10483","volume":"5","author":"AR Conery","year":"2016","unstructured":"Conery AR, Centore RC, Neiss A, Keller PJ, Joshi S, Spillane KL, Sandy P, Hatton C, Pardo E, Zawadzke L, Bommi-Reddy A, Gascoigne KE, Bryant BM, Mertz JA, Sims RJ. Bromodomain inhibition of the transcriptional coactivators CBP\/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma. Elife. 2016;5:e10483.","journal-title":"Elife"},{"key":"197_CR19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.chembiol.2010.03.006","volume":"17","author":"EM Bowers","year":"2010","unstructured":"Bowers EM, Yan G, Mukherjee C, Orry A, Wang L, Holbert MA, Crump NT, Hazzalin CA, Liszczak G, Yuan H, Larocca C, Saldanha SA, Abagyan R, Sun Y, Meyers DJ, Marmorstein R, Mahadevan LC, Alani RM, Cole PA. Virtual ligand screening of the p300\/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem Biol. 2010;17:471\u201382.","journal-title":"Chem Biol"},{"key":"197_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1021\/acsmedchemlett.5b00385","volume":"7","author":"JH Shrimp","year":"2016","unstructured":"Shrimp JH, Sorum AW, Garlick JM, Guasch L, Nicklaus MC, Meier JL. Characterizing the covalent targets of a small molecule inhibitor of the lysine acetyltransferase P300. ACS Med Chem Lett. 2016;7:151\u20135.","journal-title":"ACS Med Chem Lett"},{"key":"197_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrd4286","volume":"13","author":"P Filippakopoulos","year":"2014","unstructured":"Filippakopoulos P, Knapp S. Targeting bromodomains: epigenetic readers of lysine acetylation. Nat Rev Drug Discov. 2014;13:337\u201356.","journal-title":"Nat Rev Drug Discov"},{"key":"197_CR22","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1158\/2159-8290.CD-16-0178","volume":"6","author":"DM Munoz","year":"2016","unstructured":"Munoz DM, Cassiani PJ, Li L, Billy E, Korn JM, Jones MD, Golji J, Ruddy DA, Yu K, McAllister G, Deweck A, Abramowski D, Wan J, Shirley MD, Neshat SY, Rakiec D, De Beaumont R, Weber O, Kauffmann A, Robert McDonald E, Keen N, Hofmann F, Sellers WR, Schmelzle T, Stegmeier F, Schlabach MR. CRISPR screens provide a comprehensive assessment of cancer vulnerabilities but generate false-positive hits for highly amplified genomic regions. Cancer Discov. 2016;6:900\u201313.","journal-title":"Cancer Discov"},{"key":"197_CR23","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nbt.3235","volume":"33","author":"J Shi","year":"2015","unstructured":"Shi J, Wang E, Milazzo JP, Wang Z, Kinney JB, Vakoc CR. Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains. Nat Biotechnol. 2015;33:661\u20137.","journal-title":"Nat Biotechnol"},{"key":"197_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","volume":"153","author":"WA Whyte","year":"2013","unstructured":"Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI, Young RA. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153:307\u201319.","journal-title":"Cell"},{"key":"197_CR25","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1093\/bioinformatics\/btr189","volume":"27","author":"P Machanick","year":"2011","unstructured":"Machanick P, Bailey TL. MEME-ChIP: motif analysis of large DNA datasets. Bioinformatics. 2011;27:1696\u20137.","journal-title":"Bioinformatics"},{"key":"197_CR26","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/25166","volume":"396","author":"J Boyes","year":"1998","unstructured":"Boyes J, Byfield P, Nakatani Y, Ogryzko V. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature. 1998;396:594\u20138.","journal-title":"Nature"},{"key":"197_CR27","first-page":"2061","volume":"95","author":"GA Blobel","year":"1998","unstructured":"Blobel GA, Nakajima T, Eckner R, Montminy M, Orkin SH. CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation (transcriptional activation GATA factors adenovirus E1A protein protein\u2013protein interaction). Biochemistry. 1998;95:2061\u20136.","journal-title":"Biochemistry"},{"key":"197_CR28","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"197_CR29","doi-asserted-by":"publisher","first-page":"7690","DOI":"10.1093\/nar\/gks501","volume":"40","author":"X Lan","year":"2012","unstructured":"Lan X, Witt H, Katsumura K, Ye Z, Wang Q, Bresnick EH, Farnham PJ, Jin VX. Integration of Hi-C and ChIP-seq data reveals distinct types of chromatin linkages. Nucleic Acids Res. 2012;40:7690\u2013704.","journal-title":"Nucleic Acids Res"},{"key":"197_CR30","first-page":"11598","volume":"92","author":"R Calligaris","year":"1995","unstructured":"Calligaris R, Bottardi S, Cogoi S, Apezteguia I, Santoro C. Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor. Biochemistry. 1995;92:11598\u2013602.","journal-title":"Biochemistry"},{"key":"197_CR31","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1182\/blood-2002-11-3599","volume":"102","author":"L Rainis","year":"2003","unstructured":"Rainis L, Bercovich D, Strehl S, Teigler-Schlegel A, Stark B, Trka J, Amariglio N, Biondi A, Muler I, Rechavi G, Kempski H, Haas OA, Izraeli S. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood. 2003;102:981\u20136.","journal-title":"Blood"},{"key":"197_CR32","first-page":"4866","volume":"52","author":"VM Fazio","year":"1992","unstructured":"Fazio VM, Barrera G, Martinotti S, Farace MG, Giglioni B, Frati L, Manzari V, Dianzani MU. 4-Hydroxynonenal, a product of cellular lipid peroxidation, which modulates c-myc and globin gene expression in K562 erythroleukemic cells. Cancer Res. 1992;52:4866\u201371.","journal-title":"Cancer Res"},{"key":"197_CR33","doi-asserted-by":"crossref","unstructured":"Fulco CP, Munschauer M, Anyoha R, Munson G, Grossman SR, Perez EM, Kane M, Cleary B, Lander ES, Engreitz JM: Systematic mapping of functional enhance-promoter connections with CRISPR interference. Science 80 2016, 6056(September):aag2445.","DOI":"10.1126\/science.aag2445"},{"key":"197_CR34","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nature24028","volume":"550","author":"LM Lasko","year":"2017","unstructured":"Lasko LM, Jakob CG, Edalji RP, Qiu W, Montgomery D, Digiammarino EL, Hansen TM, Risi RM, Frey R, Manaves V, Shaw B, Algire M, Hessler P, Lam LT, Uziel T, Faivre E, Ferguson D, Buchanan FG, Martin RL, Torrent M, Chiang GG, Karukurichi K, Langston JW, Weinert BT, Choudhary C, De Vries P, Van Drie JH, McElligott D, Kesicki E, Marmorstein R, et al. Discovery of a selective catalytic p300\/CBP inhibitor that targets lineage-specific tumours. Nature. 2017;550:128\u201332.","journal-title":"Nature"},{"key":"197_CR35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrc2819","volume":"10","author":"J Riggelen van","year":"2010","unstructured":"van Riggelen J, Yetil A, Felsher DW. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer. 2010;10:301\u20139.","journal-title":"Nat Rev Cancer"},{"key":"197_CR36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nature14590","volume":"523","author":"JD Buenrostro","year":"2015","unstructured":"Buenrostro JD, Wu B, Litzenburger UM, Ruff D, Gonzales ML, Snyder MP, Chang HY, Greenleaf WJ. Single-cell chromatin accessibility reveals principles of regulatory variation. Nature. 2015;523:486\u201390.","journal-title":"Nature"},{"key":"197_CR37","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1182\/blood-2003-10-3383","volume":"103","author":"M Ahmed","year":"2004","unstructured":"Ahmed M, Sternberg A, Hall G, Thomas A, Smith O, O\u2019Marcaigh A, Wynn R, Stevens R, Addison M, King D, Stewart B, Gibson B, Roberts I, Vyas P. Natural history of GATA1 mutations in Down syndrome. Blood. 2004;103:2480\u20139.","journal-title":"Blood"},{"key":"197_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ajh.21332","volume":"84","author":"RM Ayala","year":"2009","unstructured":"Ayala RM, Mart\u00ednez-L\u00f3pez J, Alb\u00edzua E, Diez A, Gilsanz F. Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia. Am J Hematol. 2009;84:79\u201386.","journal-title":"Am J Hematol"},{"key":"197_CR39","doi-asserted-by":"publisher","first-page":"e68601","DOI":"10.1371\/journal.pone.0068601","volume":"8","author":"JT Caldwell","year":"2013","unstructured":"Caldwell JT, Edwards H, Dombkowski AA, Buck SA, Matherly LH, Ge Y, Taub JW. Overexpression of GATA1 confers resistance to chemotherapy in acute megakaryocytic Leukemia. PLoS ONE. 2013;8:e68601.","journal-title":"PLoS ONE"},{"key":"197_CR40","doi-asserted-by":"publisher","first-page":"8957","DOI":"10.1128\/JVI.77.16.8957-8951.2003","volume":"77","author":"M Wiznerowicz","year":"2003","unstructured":"Wiznerowicz M, Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol. 2003;77:8957\u201361.","journal-title":"J Virol"},{"key":"197_CR41","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.1246981","volume":"343","author":"T Wang","year":"2014","unstructured":"Wang T, Wei JJ, Sabatini DM, Lander ES. Genetic screens in human cells using the CRISPR-Cas9 system. Science. 2014;343:80\u20134.","journal-title":"Science"},{"key":"197_CR42","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods. 2014;11:783\u20134.","journal-title":"Nat Methods"},{"key":"197_CR43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2307\/3001913","volume":"5","author":"JW Tukey","year":"1949","unstructured":"Tukey JW. Comparing individual means in the analysis of variance. Biometrics. 1949;5:99.","journal-title":"Biometrics"},{"key":"197_CR44","doi-asserted-by":"publisher","first-page":"32952","DOI":"10.1038\/srep32952","volume":"6","author":"V Garc\u00eda-Carpizo","year":"2016","unstructured":"Garc\u00eda-Carpizo V, Sarmentero J, Han B, Gra\u00f1a O, Ruiz-Llorente S, Pisano DG, Serrano M, Brooks HB, Campbell RM, Barrero MJ. NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation. Sci Rep. 2016;6:32952.","journal-title":"Sci Rep"},{"key":"197_CR45","unstructured":"Gra\u00f1a O, Rubio-Camarillo M, Fdez-Riverola F, Pisano DG, Glez-Pe\u00f1a D. Nextpresso: Next Generation Sequencing Expression Analysis Pipeline. Curr Bioinform 2016, (ext 3062):1\u201310 (in press)."},{"key":"197_CR46","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.1630","volume":"28","author":"CY McLean","year":"2010","unstructured":"McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, Wenger AM, Bejerano G. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol. 2010;28:495\u2013501.","journal-title":"Nat Biotechnol"},{"key":"197_CR47","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/gb-2011-12-8-r83","volume":"12","author":"T Liu","year":"2011","unstructured":"Liu T, Ortiz JA, Taing L, Meyer CA, Lee B, Zhang Y, Shin H, Wong SS, Ma J, Lei Y, Pape UJ, Poidinger M, Chen Y, Yeung K, Brown M, Turpaz Y, Liu XS. Cistrome: an integrative platform for transcriptional regulation studies. Genome Biol. 2011;12:R83.","journal-title":"Genome Biol"},{"key":"197_CR48","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1101\/gr.229102","volume":"12","author":"WJ Kent","year":"2002","unstructured":"Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. The human genome browser at UCSC. Genome Res. 2002;12:996\u20131006.","journal-title":"Genome Res"},{"key":"197_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1\u201313.","journal-title":"Nucleic Acids Res"},{"key":"197_CR50","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44\u201357.","journal-title":"Nat Protoc"},{"key":"197_CR51","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134.","journal-title":"Cancer Discov"},{"key":"197_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"BE Bernstein","year":"2012","unstructured":"Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57\u201374.","journal-title":"Nature"}],"container-title":["Epigenetics & Chromatin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-018-0197-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13072-018-0197-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-018-0197-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T07:13:47Z","timestamp":1661411627000},"score":1,"resource":{"primary":{"URL":"https:\/\/epigeneticsandchromatin.biomedcentral.com\/articles\/10.1186\/s13072-018-0197-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,8]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["197"],"URL":"https:\/\/doi.org\/10.1186\/s13072-018-0197-x","relation":{},"ISSN":["1756-8935"],"issn-type":[{"value":"1756-8935","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,8]]},"assertion":[{"value":"24 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"30"}}